Skip to main content
TipRanks
Go Ultimate75% OFF

We Can Medicines Co., Ltd. (6929) Q2 2022 Earnings Report

TW:6929 Q2 2022 EPS Results

Actual EPS
TWD 2.25
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
TWD 0.92

TW:6929 Q2 2022 Revenue Results

Actual Revenue
TWD 1.73B
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2022
Date
12/01/2022
Time
Before Open
Conference Call
Thursday, December 1, 2022
TW:6929 Upcoming Earnings

We Can Medicines Co., Ltd.'s next earnings date is estimated for March 17, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:6929 Earnings History

TW:6929 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 17, 20272026 (Q4)―--0.62――
Nov 06, 20262026 (Q3)―--0.58―
Jul 31, 20262026 (Q2)―-0.32-0.15-114.19% (-0.17)
Apr 29, 20262026 (Q1)―-0.21-0.2822.83% (+0.06)
Feb 23, 20262025 (Q4)―-0.62-0.7517.90% (+0.14)
Nov 07, 20252025 (Q3)―-0.58-0.47-23.78% (-0.11)
Aug 07, 20252025 (Q2)―-0.15-0.08-89.74% (-0.07)
May 12, 20252025 (Q1)―-0.280.27-202.22% (-0.55)
Mar 11, 20252024 (Q4)―-0.750.15-612.93% (-0.90)
Nov 12, 20242024 (Q3)0.00-0.47-0.1-366.34% (-0.37)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed